Pharmabiz6m
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses: Basel Friday, September 20, 2024, 09:00 Hrs [IST] Roche announc ...
Pharmabiz1h
Karnataka DC dept launches online tracking system for sale of tapentadol as misuse reported
Karnataka DC dept launches online tracking system for sale of tapentadol as misuse reported: Nandita Vijaysimha, Bengaluru Friday, September 20, 2024, 08:00 Hrs [IST] The Karnatak ...
Pharmabiz1h
DCC recommends issuance of advisory to SLAs for monitoring quality of eye drops in packages
The Drugs Consultative Committee (DCC) has recommended to the national drug regulatory authority to issue an advisory to the State Licensing Authorities to monitor the quality of eye drops in packages ...
Pharmabiz1h
PvPI and ADR monitoring & reporting should be made part of pharmacy curriculum: Dr B Suresh
Peethaambaran Kunnathoor, Chennai Friday, September 20, 2024, 08:00 Hrs [IST] ...
Pharmabiz1h
Gujarat pharma leaders gather in Vapi to discuss Revised Schedule M guidelines
Gujarat pharma leaders gather in Vapi to discuss Revised Schedule M guidelines: Shardul Nautiyal, Mumbai Friday, September 20, 2024, 08:00 Hrs [IST] In a pivotal move towards impr ...
Pharmabiz1h
Government tightens limits on interest equalisation scheme for exporters, caps announced for 2024
The Directorate General of Foreign Trade (DGFT) has issued an important amendment to the Interest Equalisation Scheme (IES), providing updated guidelines for exporters. In a Trade Notice, the ...
Pharmabiz16h
SAKCON 2024 proves to be an event par excellence on patient centric care
In a landmark moment for the healthcare industry, the School of Business Management, NMIMS, Mumbai, in collaboration with ...
Pharmabiz10h
Study shows use of metformin in adults with diabetes linked to lower risk of long Covid
Adults who use the prescription drug metformin to treat their type 2 diabetes have a lower risk of developing long Covid or dying after a Covid-19 infection than people with diabetes who take other ...
Pharmabiz23h
“Get it right, make it safe!”: WHO highlights safe diagnosis during global campaign for patient safety
Recognizing the urgent need for a broad-based effort globally to reduce errors in medical diagnosis, the World Health Organization (WHO) is calling on all stakeholders to “Get it right, make it safe!” ...
Pharmabiz16h
Oxymed introduces 'Try & Buy' scheme for CPAP machines to address rising sleep apnoea
Oxymed introduces 'Try & Buy' scheme for CPAP machines to address rising sleep apnoea: Our Bureau, Mumbai Thursday, September ...
Pharmabiz21h
GE HealthCare’s MIM Software receives US FDA clearance of new Centiloid scaling tool to quantify amyloid plaque in brain imaging
GE HealthCare’s MIM Software receives US FDA clearance of new Centiloid scaling tool to quantify amyloid plaque in brain imaging: Chicago Thursday, September 19, 2024, 12:00 Hrs ...
Pharmabiz15h
BFI and BIRAC ink a ‘Letter of Intent’ to accelerate biomedical innovation
BFI and BIRAC ink a ‘Letter of Intent’ to accelerate biomedical innovation: Our Bureau, Bengaluru Thursday, September 19, 2024, 17:15 Hrs [IST] Blockchain for Impact (BFI), th ...